Home > Compound List > Product Information
Hydrochlorothiazide_Molecular_structure_CAS_58-93-5)
Click picture or here to close

Hydrochlorothiazide

Catalog No. DB00999 Name DrugBank
CAS Number 58-93-5 Website http://www.ualberta.ca/
M. F. C7H8ClN3O4S2 Telephone (780) 492-3111
M. W. 297.73912 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 872

SYNONYMS

IUPAC name
6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
IUPAC Traditional name
hydrochlorothiazide
Brand Name
Esimil
Cidrex
Ziac
Hypothiazide
Aquarills
Dichlorotride
Diu-Melusin
Drenol
Fluvin
Hidril
Hydrozide
Megadiuril
Nefrix
Servithiazid
Vetidrex
Aquarius
Bremil
Caplaril
Chlorzide
Dichlorosal
Dichlotiazid
Dichlotride
Diclotride
Dicyclotride
Direma
Disalunil
Esidrex
Hidrochlortiazid
Hidroronol
Hydrothide
Jen-Diril
Neoflumen
Newtolide
Thlaretic
Timolide
Urodiazin
Acuretic
Aldoril
Apresazide
Capozide
Chlorosulthiadil
Hidrotiazida
Hydril
Hydro-Aquil
Hydro-Diuril
Hydrodiuretic
Hydropres
Hydrosaluric
Hypothiazid
Idrotiazide
Ivaugan
Lotensin Hct
Maschitt
Moduretic
Neo-Codema
Panurin
Ro-Hydrazide
Thiaretic
Thiuretic
Synonyms
Dihydrochlorothiazidum
Dihydroxychlorothiazidum
Dihydrochlorurit
Hydrochlorothiazid
HCTZ
HCZ
Dihydrochlorurite
Dihydrochlorothiazid
Dihydrochlorothiazide
Hydrochlorthiazide

DATABASE IDS

CAS Number 58-93-5

PROPERTIES

Hydrophobicity(logP) -0.5
Solubility 0.7 mg/mL

DETAILS

Description (English)
Item Information
Drug Groups approved
Description A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It has been used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. [PubChem]
Indication For the treatment of high blood pressure and management of edema.
Pharmacology Thiazides such as hydrochlorothiazide promote water loss from the body (diuretics). They inhibit Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue.
Toxicity The most common signs and symptoms observed are those caused by electrolyte depletion (hypokalemia, hypochloremia, hyponatremia) and dehydration resulting from excessive diuresis. If digitalis has also been administered, hypokalemia may accentuate cardiac arrhythmias. The oral LD50 of hydrochlorothiazide is greater than 10 g/kg in the mouse and rat.
Affected Organisms
Humans and other mammals
Biotransformation Hydrochlorothiazide is not metabolized.
Absorption 50-60%
Half Life 5.6 and 14.8 hours
Protein Binding 67.9%
Elimination Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney. Hydrochlorothiazide crosses the placental but not the blood-brain barrier and is excreted in breast milk.
External Links
Wikipedia
RxList
Drugs.com

REFERENCES